R Squared’s Replimune Group REPL Stock Holding History

R Squared’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-180	Closed	-$2.18K	–	1224
2024 Q4	$2.18K	Buy	+180	New	+$2.19K	﹤0.01%	1458

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R Squared's REPL Position: Q1 2025 in Review

R Squared sold out of Replimune Group (REPL) in Q1 2025, closing a stake of 180 shares — an estimated $2.18K sold.

R Squared first reported a position in REPL in Q4 2024 and held it in 1 quarter. The position peaked at $2.18K in Q4 2024. 167 funds tracked by Wall St. Rank hold REPL as of Q1 2025.

R Squared reported no remaining Replimune Group position as of Q1 2025 after selling out during the quarter.
R Squared sold 180 Replimune Group shares in Q1 2025, an estimated $2.18K.
R Squared first reported a position in Replimune Group in Q4 2024 and held it in 1 quarter.
R Squared's Replimune Group position peaked at $2.18K in Q4 2024.
167 funds tracked by Wall St. Rank held Replimune Group as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.